Testing effectiveness (Phase 2)Active Not RecruitingNCT04722172
What this trial is testing
A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL
Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Memorial Sloan Kettering Cancer Center 55